Management ChangeJul 26, 2026, 04:01 PM
RxSight Grants Equity to New CEO Aziz Mottiwala
AI Summary
RxSight, Inc. announced that on July 24, 2026, it granted inducement stock options and restricted stock units (RSUs) to Aziz Mottiwala, its new President and Chief Executive Officer. This grant was made in connection with his commencement of employment and includes 571,286 shares in stock options and 2,312,138 shares in RSUs. The stock options have an exercise price of $5.19 per share. The awards are subject to specific vesting schedules and were granted as inducements under Nasdaq Listing Rule 5635(c)(4).
Key Highlights
- RxSight appointed Aziz Mottiwala as its new President and Chief Executive Officer.
- Granted 571,286 inducement stock options to Mr. Mottiwala.
- Stock options have an exercise price of $5.19 per share.
- Granted 2,312,138 inducement restricted stock units (RSUs) to Mr. Mottiwala.
- Stock options vest 25% after one year, then 1/48th monthly thereafter.
- RSUs vest 20% after one year, 20% after two years, and 60% after three years.
- Awards granted under the RxSight, Inc. 2026 Inducement Equity Incentive Plan.
Price Impact
More from RXST